Shott Pharma Ag & Co. Kgaa

Schott Ag

Schott Pharma Schweiz Ag

Schott Pharma Ag & Co Kgaa

Florence Buscke

Eveline Rudigier-Voigt

Robert Frost

Uwe Rothhaar

Sylvia Biedenbender

Bernhard Hladik

Jovana Djordjevic-Reiß

Sebastian Brechler

Uwe Rothaar

A glass vial includes a base including a boron-containing multicomponent glass and a vial opening and holds a liquid active pharmaceutical ingredient formulation. The glass vial has a total volume of &#x3c;4.5 mL. A filling level of the glass vial with the active pharmaceutical ingredient formulation is not more than 0.25 and a concentration of boron ions, measured at a measurement site below a plane of a middle of the glass vial using a concentration depth profile at a depth in a range from 10 to 30 nm, has a value, averaged over the measurements of the concentration depth profile, that has an excess increase of not more than 30% compared to a concentration of boron ions measured using a concentration depth profile at a depth in a range from 10 to 30 nm with a measurement site in the plane of the middle of the glass vial.

Glass vial with increased chemical stability

Growing community of inventors

Mainz, Germany

Florence Buscke